Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2016, Article ID 7617894, 10 pages
http://dx.doi.org/10.1155/2016/7617894
Research Article

Paramagnetic Nanoparticle-Based Targeting Theranostic Agent for C6 Rat Glioma Cell

1Department of Radiological Science, Konyang University, Daejeon 302-718, Republic of Korea
2College of Medicine, Konyang University, Daejeon 302-718, Republic of Korea

Received 30 December 2015; Revised 9 March 2016; Accepted 3 April 2016

Academic Editor: Muhammet S. Toprak

Copyright © 2016 Seong-Pyo Hong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Grobner and F. C. Prischl, “Gadolinium and nephrogenic systemic fibrosis,” Kidney International, vol. 72, no. 3, pp. 260–264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Wang, D. Short, N. J. Sebire et al., “Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE),” Annals of Oncology, vol. 19, no. 9, pp. 1578–1583, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Bardhan, S. Lal, A. Joshi, and N. J. Halas, “Theranostic nanoshells: from probe design to imaging and treatment of cancer,” Accounts of Chemical Research, vol. 44, no. 10, pp. 936–946, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Wang, X. Sun, H. He et al., “A two-component active targeting theranostic agent based on graphene quantum dots,” Journal of Materials Chemistry B, vol. 3, no. 17, pp. 3583–3590, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. K. Yu, J. Park, and S. Jon, “Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy,” Theranostics, vol. 2, no. 1, pp. 3–44, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Xie, S. Lee, and X. Chen, “Nanoparticle-based theranostic agents,” Advanced Drug Delivery Reviews, vol. 62, no. 11, pp. 1064–1079, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Y. Choi, E. J. Jeon, H. Y. Yoon et al., “Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer,” Biomaterials, vol. 33, no. 26, pp. 6186–6193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. E. Lee, N. Lee, T. Kim, J. Kim, and T. Hyeon, “Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications,” Accounts of Chemical Research, vol. 44, no. 10, pp. 893–902, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Yoo, J.-H. Lee, T.-H. Shin, and J. Cheon, “Theranostic magnetic nanoparticles,” Accounts of Chemical Research, vol. 44, no. 10, pp. 863–874, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. R. R. Edelman and S. Warach, “Magnetic resonance imaging,” The New England Journal of Medicine, vol. 328, no. 10, pp. 708–716, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Caravan, J. J. Ellison, T. J. McMurry, and R. B. Lauffer, “Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications,” Chemical Reviews, vol. 99, no. 9, pp. 2293–2352, 1999. View at Publisher · View at Google Scholar
  12. J. Y. Park, M. J. Baek, E. S. Choi et al., “Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images,” ACS Nano, vol. 3, no. 11, pp. 3663–3669, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-S. Yoon, B.-L. Lee, K. S. Lee et al., “Surface modification of exfoliated layered gadolinium hydroxide for the development of multimodal contrast agents for MRI and fluorescence imaging,” Advanced Functional Materials, vol. 19, no. 21, pp. 3375–3380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Lin, S. Li, H. H. Kim et al., “Complete separation of magnetic nanoparticles via chemical cleavage of dextran by ethylenediamine for intracellular uptake,” Journal of Materials Chemistry, vol. 20, no. 3, pp. 444–447, 2010. View at Publisher · View at Google Scholar
  15. C. Tassa, S. Y. Shaw, and R. Weissleder, “Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy,” Accounts of Chemical Research, vol. 44, no. 10, pp. 842–852, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. McDonald and K. L. Watkin, “Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles,” Academic Radiology, vol. 13, no. 4, pp. 421–427, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Dai, M. Du, Y. Liu, G. Liu, Q. Liu, and X. Zhang, “Folic acid-conjugated glucose and dextran coated iron oxide nanoparticles as MRI contrast agents for diagnosis and treatment response of rheumatoid arthritis,” Journal of Materials Chemistry B, vol. 2, no. 16, pp. 2240–2247, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Kumar, A. M. Nightingale, S. H. Krishnadasan et al., “Direct synthesis of dextran-coated superparamagnetic iron oxide nanoparticles in a capillary-based droplet reactor,” Journal of Materials Chemistry, vol. 22, no. 11, pp. 4704–4708, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Nakamura, N. Nakajima, K. Matsumura, and S.-H. Hyon, “Water-soluble taxol conjugates with dextran and targets tumor cells by folic acid immobilization,” Anticancer Research, vol. 30, no. 3, pp. 903–909, 2010. View at Google Scholar · View at Scopus
  20. P. Wunderbaldinger, L. Josephson, and R. Weissleder, “Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents,” Academic Radiology, vol. 9, no. 2, pp. S304–S306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Caravan, “Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action,” Accounts of Chemical Research, vol. 42, no. 7, pp. 851–862, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Lu, J. Wu, J. Wu et al., “Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells,” Molecular Pharmaceutics, vol. 4, no. 5, pp. 707–712, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Zhang, S. Huey Lee, and S.-S. Feng, “Folate-decorated poly (lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery,” Biomaterials, vol. 28, no. 10, pp. 1889–1899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. F. Ross, P. K. Chaudhuri, and M. Ratnam, “Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines: physiologic and clinical implications,” Cancer, vol. 73, no. 9, pp. 2432–2443, 1994. View at Google Scholar · View at Scopus
  25. C. Müller, A. Hohn, P. A. Schubiger, and R. Schibli, “Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 9, pp. 1007–1016, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Saul, A. Annapragada, J. V. Natarajan, and R. V. Bellamkonda, “Controlled targeting of liposomal doxorubicin via the folate receptor in vitro,” Journal of Controlled Release, vol. 92, no. 1-2, pp. 49–67, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. E. K. Rowinsky and R. C. Donehower, “Paclitaxel (taxol),” The New England Journal of Medicine, vol. 332, no. 15, pp. 1004–1014, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. T. K. Jain, J. Richey, M. Strand, D. L. Leslie-Pelecky, C. A. Flask, and V. Labhasetwar, “Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging,” Biomaterials, vol. 29, no. 29, pp. 4012–4021, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Shan, S. Cui, C. Du et al., “A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy,” Biomaterials, vol. 33, no. 1, pp. 146–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. T. López, S. Recillas, P. Guevara, J. Sotelo, M. Alvarez, and J. A. Odriozola, “Pt/TiO2 brain biocompatible nanoparticles: GBM treatment using the C6 model in Wistar rats,” Acta Biomaterialia, vol. 4, no. 6, pp. 2037–2044, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. W. Seo, J. Ang, L. M. Mahakian et al., “Self-assembled 20-nm 64Cu-micelles enhance accumulation in rat glioblastoma,” Journal of Controlled Release, vol. 220, pp. 51–60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Stojković, A. Podolski-Renić, J. Dinić et al., “Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin,” Experimental Cell Research, vol. 335, no. 2, pp. 248–257, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-G. Han, J. Xu, Z.-G. Li, G.-G. Ren, and Z. Yang, “In vitro toxicity of multi-walled carbon nanotubes in C6 rat glioma cells,” NeuroToxicology, vol. 33, no. 5, pp. 1128–1134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Tang, G. Fang, Y. Gao et al., “Lipid-albumin nanoassemblies co-loaded with borneol and paclitaxel for intracellular drug delivery to C6 glioma cells with P-gp inhibition and its tumor targeting,” Asian Journal of Pharmaceutical Sciences, vol. 10, no. 5, pp. 363–371, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Tagami, Y. Imao, S. Ito, A. Nakada, and T. Ozeki, “Simple and effective preparation of nano-pulverized curcumin by femtosecond laser ablation and the cytotoxic effect on C6 rat glioma cells in vitro,” International Journal of Pharmaceutics, vol. 468, no. 1-2, pp. 91–96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-L. Bridot, A.-C. Faure, S. Laurent et al., “Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging,” Journal of the American Chemical Society, vol. 129, no. 16, pp. 5076–5084, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. A. T. M. Anishur Rahman, P. Majewski, and K. Vasilev, “Gd2O3 nanoparticles: Size-dependent nuclear magnetic resonance,” Contrast Media and Molecular Imaging, vol. 8, no. 1, pp. 92–95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. T. S. Renuga Devi and S. Gayathri, “FTIR And FT-Raman spectral analysis of Paclitaxel drugs,” International Journal of Pharmaceutical Sciences Review and Research, vol. 2, no. 2, pp. 106–110, 2010. View at Google Scholar · View at Scopus
  39. J. Zhang, S. Rana, R. S. Srivastava, and R. D. K. Misra, “On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles,” Acta Biomaterialia, vol. 4, no. 1, pp. 40–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. Q. Yuan, S. Hein, and R. D. K. Misra, “New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: synthesis, characterization and in vitro drug delivery response,” Acta Biomaterialia, vol. 6, no. 7, pp. 2732–2739, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Bhattacharya, M. Das, D. Mishra et al., “Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging,” Nanoscale, vol. 3, no. 4, pp. 1653–1662, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. R. W. Brown, Y.-C. Norman Cheng, E. Mark Haacke, M. R. Thompson, and R. Venkatesan, Magnetic Resonance Imaging: Physical Principles and Sequence Design, John Wiley & Sons, 2014.